Aurora continues to expand its international footprint after establishing a first-mover advantage in most of the 24 countries in which it operates, Singer told “Fast Money” host Melissa Lee.
The U.S. market is “too big to ignore,” Singer said, adding that the company is in the middle of “creating a very unique strategy” to address the CBD segment within existing federal laws that are likely to ease over time.
The company’s Australis Capital subsidiary, a small multistate operator, will “play a part” in Aurora’s broader U.S. strategy, he said.
Aurora is evaluating new partnerships with the help of strategic adviser Nelson Peltz, Singer said. The high-profile activist investor has many connections within the consumer goods and pharmaceutical spaces, he said.
The ultimate “end-game” for Aurora to finalize and sign an agreement with a major consumer products company, the exec said.
“They take time [and] we are very patient,” he said.
Road To Profit
Aurora offered the Street a 2019 outlook in January that forces the company to take a “very disciplined” approach to its business, Singer said. One of the financial metrics includes a path to becoming EBITDA-positive in the fiscal fourth quarter.
Based on the company’s first quarter performance, Aurora is “on track” to hit its guidance, the executive chairman said.
“That’s a game changer for us.”
Photo courtesy of Aurora Cannabis.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.